# Systematic review of Chinese medicine for the treatment of atherosclerosis

## TL;DR

This paper reviews Chinese medicine's potential in treating atherosclerosis, focusing on its mechanisms and clinical evidence.

## Contribution

The study systematically summarizes preclinical and clinical evidence for Chinese medicine's role in atherosclerosis treatment.

## Key findings

- 116 preclinical and 6 clinical studies were analyzed for Chinese medicine's effects on atherosclerosis.
- Natural compounds from Chinese herbs show promise in targeting atherosclerosis mechanisms.
- Seven RCTs were reviewed to evaluate clinical efficacy of Chinese medicine interventions.

## Abstract

Atherosclerosis (AS) is a chronic inflammatory metabolic disease strongly associated with risk factors, including hypertension, hyperlipidemia, hyperglycemia, and hyperuricemia. AS serves as the pathological foundation for numerous cardiovascular diseases (CVDs), and it remains a major threat to global health. However, the underlying mechanisms driving AS development are incompletely understood. Elucidating the pathogenesis and key influencing factors of AS is critical for identifying novel preventive strategies and therapeutic approaches.

We searched PubMed and Web of Science for relevant studies. We selected relevant English research articles published between 2012 and 2024. Afterward,we analyzed and summarized the pharmacological effects and molecular mechanisms of these Chinese medicines.

Through our search and exclusion criteria, a total of 116 preclinical studies and 6 clinical research articles were found.

Traditional Chinese medicine (TCM), with over 2000 years of clinical application, offers a rich source of potential interventions. Integrating modern medical technologies allows for the reevaluation of TCM from a natural compound perspective. This review comprehensively summarizes the mechanisms by which single herbal medicines (SHMs) and their derived natural compounds (NCs) exert effects against AS on the basis of preclinical evidence and analysis of seven selected double-blind, randomized, placebo-controlled clinical trials (RCTs).